atcormedical.com
at the heart of cardiovascular management.
CONTACT US SITE MAP SEARCH
AtCor Medical is the leading developer and marketer of noninvasive technolosies and 
		complementary services for the measurement and management of central blood pressure and arterial stiffness.
Our SphygmoCor systems are the global gold standard in diagnosis and patient
		 management, pharmacutical clinical trials and research.

ANALYSTS' REPORTS AND INTERVIEW

RB Milestone Group (RBMG) has initiated coverage of AtCor’s stock. Please click here to view the report.

RBMG is an independent equity research firm whose chief focal points lie within the Healthcare, Technology and Energy sectors; more specifically, within the small, micro and nano-cap size bracket.

RB Milestone Group, New York, and Taylor Collison Sharebrokers and Investment Advisors, Sydney, now actively follow AtCor Medical.

Please click here to view recent reports and interview scripts.
VIEW PRODUCT DEMONSTRATION

The SphygmoCor system provides a quick and non-invasive method of obtaining key cardiovascular data thereby enhancing the treatment and management of patients.

Please click here to view a brief demonstration of the steps involved in taking a SphygmoCor measurement. 

NEWS

2 February 2010 : Central BP a Superior Determinant of Left Ventricular Hypertrophy

28 January 2010 : 1st Half Market update

28 January 2010 : Second Quarter Report - Appendix 4C

28 October 2009 : Cardiovascular Event Threshold Identified

21 October 2009 : 2009 Annual General Meeting - CEO's Presentation


 

Copyright © 2010 AtCor Medical Pty Limited | Disclaimer | Privacy